Advisory Services Network’s Voyager Therapeutics VYGR Stock Holding History

Advisory Services Network’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,400	Closed	-$31K	–	3196
2021 Q2	$31K	Buy	+7,400	New	+$33.5K	﹤0.01%	2265
2021 Q1	–	Sell	-220	Closed	-$2K	–	2920
2020 Q4	$2K	Hold	220	–	–	﹤0.01%	3055
2020 Q3	$2K	Buy	+220	New	+$2.58K	﹤0.01%	3207
2020 Q2	–	Sell	-220	Closed	-$2K	–	2709
2020 Q1	$2K	Buy	+220	New	+$2.52K	﹤0.01%	2792

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisory Services Network's VYGR Position: Q3 2021 in Review

Advisory Services Network sold out of Voyager Therapeutics (VYGR) in Q3 2021, closing a stake of 7,400 shares — an estimated $31K sold.

Advisory Services Network first reported a position in VYGR in Q1 2020 and held it in 4 quarters. The position peaked at $31K in Q2 2021. 69 funds tracked by Wall St. Rank hold VYGR as of Q3 2021.

Advisory Services Network reported no remaining Voyager Therapeutics position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 7,400 Voyager Therapeutics shares in Q3 2021, an estimated $31K.
Advisory Services Network first reported a position in Voyager Therapeutics in Q1 2020 and held it in 4 quarters.
Advisory Services Network's Voyager Therapeutics position peaked at $31K in Q2 2021.
69 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.